Analysis of the costs for the laboratory of flow cytometry screening of urine samples before culture

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Analysis of the costs for the laboratory of flow cytometry screening of urine samples before culture. / Paattiniemi, Eeva-liisa; Karumaa, Santra; Viita, Anna-Mari; Kärpänoja, Pauliina; Mäkelä, Marjukka; Isojärvi, Jaana; Sarkkinen, Hannu.

In: Infectious Diseases, Vol. 49, No. 3, 2017, p. 217-222.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Paattiniemi, E, Karumaa, S, Viita, A-M, Kärpänoja, P, Mäkelä, M, Isojärvi, J & Sarkkinen, H 2017, 'Analysis of the costs for the laboratory of flow cytometry screening of urine samples before culture', Infectious Diseases, vol. 49, no. 3, pp. 217-222. https://doi.org/10.1080/23744235.2016.1239028

APA

Paattiniemi, E., Karumaa, S., Viita, A-M., Kärpänoja, P., Mäkelä, M., Isojärvi, J., & Sarkkinen, H. (2017). Analysis of the costs for the laboratory of flow cytometry screening of urine samples before culture. Infectious Diseases, 49(3), 217-222. https://doi.org/10.1080/23744235.2016.1239028

Vancouver

Paattiniemi E, Karumaa S, Viita A-M, Kärpänoja P, Mäkelä M, Isojärvi J et al. Analysis of the costs for the laboratory of flow cytometry screening of urine samples before culture. Infectious Diseases. 2017;49(3):217-222. https://doi.org/10.1080/23744235.2016.1239028

Author

Paattiniemi, Eeva-liisa ; Karumaa, Santra ; Viita, Anna-Mari ; Kärpänoja, Pauliina ; Mäkelä, Marjukka ; Isojärvi, Jaana ; Sarkkinen, Hannu. / Analysis of the costs for the laboratory of flow cytometry screening of urine samples before culture. In: Infectious Diseases. 2017 ; Vol. 49, No. 3. pp. 217-222.

Bibtex

@article{cfe7bd317780434faa954b4feeca92c0,
title = "Analysis of the costs for the laboratory of flow cytometry screening of urine samples before culture",
abstract = "Urine culture samples comprise a large proportion of the workload in clinical microbiology laboratories, and most of the urine samples show no growth or insignificant growth. A flow cytometry-based analyzer (Sysmex Corporation, Japan) has been used to screen out negative urine samples prior to culture in the P{\"a}ij{\"a}t-H{\"a}me district. We applied decision analytic modelling to analyze, from a laboratory perspective, the economic feasibility of the screening method as compared to culture only (conventional method) for diagnosis of urinary tract infection. Our model suggests that the least costly analytical strategy is the conventional method. The incremental cost of screening is €0.29/sample. Although laboratory costs are higher, considerable savings on workload can be achieved. Furthermore, screening has numerous benefits on the treatment process of a patient that well warrant the use of the screening method. We conclude that the incremental cost of screening the samples is worth the expense.",
author = "Eeva-liisa Paattiniemi and Santra Karumaa and Anna-Mari Viita and Pauliina K{\"a}rp{\"a}noja and Marjukka M{\"a}kel{\"a} and Jaana Isoj{\"a}rvi and Hannu Sarkkinen",
year = "2017",
doi = "10.1080/23744235.2016.1239028",
language = "English",
volume = "49",
pages = "217--222",
journal = "Infectious Diseases",
issn = "2374-4235",
publisher = "Taylor & Francis",
number = "3",

}

RIS

TY - JOUR

T1 - Analysis of the costs for the laboratory of flow cytometry screening of urine samples before culture

AU - Paattiniemi, Eeva-liisa

AU - Karumaa, Santra

AU - Viita, Anna-Mari

AU - Kärpänoja, Pauliina

AU - Mäkelä, Marjukka

AU - Isojärvi, Jaana

AU - Sarkkinen, Hannu

PY - 2017

Y1 - 2017

N2 - Urine culture samples comprise a large proportion of the workload in clinical microbiology laboratories, and most of the urine samples show no growth or insignificant growth. A flow cytometry-based analyzer (Sysmex Corporation, Japan) has been used to screen out negative urine samples prior to culture in the Päijät-Häme district. We applied decision analytic modelling to analyze, from a laboratory perspective, the economic feasibility of the screening method as compared to culture only (conventional method) for diagnosis of urinary tract infection. Our model suggests that the least costly analytical strategy is the conventional method. The incremental cost of screening is €0.29/sample. Although laboratory costs are higher, considerable savings on workload can be achieved. Furthermore, screening has numerous benefits on the treatment process of a patient that well warrant the use of the screening method. We conclude that the incremental cost of screening the samples is worth the expense.

AB - Urine culture samples comprise a large proportion of the workload in clinical microbiology laboratories, and most of the urine samples show no growth or insignificant growth. A flow cytometry-based analyzer (Sysmex Corporation, Japan) has been used to screen out negative urine samples prior to culture in the Päijät-Häme district. We applied decision analytic modelling to analyze, from a laboratory perspective, the economic feasibility of the screening method as compared to culture only (conventional method) for diagnosis of urinary tract infection. Our model suggests that the least costly analytical strategy is the conventional method. The incremental cost of screening is €0.29/sample. Although laboratory costs are higher, considerable savings on workload can be achieved. Furthermore, screening has numerous benefits on the treatment process of a patient that well warrant the use of the screening method. We conclude that the incremental cost of screening the samples is worth the expense.

U2 - 10.1080/23744235.2016.1239028

DO - 10.1080/23744235.2016.1239028

M3 - Journal article

C2 - 27766919

VL - 49

SP - 217

EP - 222

JO - Infectious Diseases

JF - Infectious Diseases

SN - 2374-4235

IS - 3

ER -

ID: 179313608